Alizé Pharma 3 raises $75M in Series A

World |  News | 0 Comment | 31 Jul, 2019

Alizé Pharma 3, a company specialized in developing therapeutic peptides for rare endocrine and metabolic diseases has completed a €67 million Series A financing round. The...Read more

Pfizer completes acquisition of Array Biopharma

World |  News | 0 Comment | 31 Jul, 2019

Pfizer Inc.  announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of targ...Read more

Exact Sciences inks $2.8B deal with Genomic Health

World |  News | 0 Comment | 31 Jul, 2019

US based Exact Sciences Corp. and Genomic Health, Inc. have announced that the companies have entered into a definitive agreement under which Exact Sciences will combine with Geno...Read more

Dassault Systèmes and FDA extend collaboration to accelerate access to new treatments

World |  News | 0 Comment | 30 Jul, 2019

Dassault Systèmes has announced the five-year extension of its collaboration with the U.S. Food and Drug Administration. The 3DEXPERIENCE platform will be used to develop a new digit...Read more

Mylan and Pfizer to create a new company

World |  News | 0 Comment | 30 Jul, 2019

Mylan and Pfizer Inc. have announced a definitive agreement to combine Mylan with Upjohn, Pfizer’s off-patent branded and generic established medicines business, creating a new global...Read more

Sanofi provides update on Zynquista type 2 diabetes program

World |  News | 0 Comment | 29 Jul, 2019

Sanofi has announced topline results from three Phase 3 trials of ZynquistaTM (sotagliflozin) in adults living with type 2 diabetes from the InSynchrony clinical program. Given the pri...Read more

Hikma, Civica to reduce generic drug shortages in the US

World |  News | 0 Comment | 22 Jul, 2019

Hikma Pharmaceuticals PLC,the multinational generic pharmaceutical company and Civica Rx (Civica, Inc.) have announced a five-year agreement to manufacture and supply Civica’s growing...Read more

US researchers design 3D printed indigestible pill

World |  News | 0 Comment | 29 Jul, 2019

A research team led by Tufts University engineers in the US has developed a 3D printed ingestible pill that samples bacteria found in the gut, known as the microbiome, as it passes through ...Read more

PerkinElmer to expand At Home health services

World |  News | 0 Comment | 26 Jul, 2019

PerkinElmer, Inc. and EverlyWell, Inc. have announced a new collaboration designed to accelerate innovation in and accessibility of consumer-initiated health testing, by addi...Read more

Cipla USA acquires worldwide rights for UTI drug

World |  News | 0 Comment | 25 Jul, 2019

Cipla USA Inc., a wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited, announced the acquisition of the prescription drug ZEMDRI (Plazomicin) from A...Read more

Olon expands microbial GMP capabilities in Capua site

World |  News | 0 Comment | 24 Jul, 2019

Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier has recently started the construct...Read more

Sanofi signs deal for exclusive US OTC rights to Tamiflu

World |  News | 0 Comment | 24 Jul, 2019

Sanofi signed an agreement with Roche for the exclusive over-the-counter (OTC) rights to Tamiflu® for the prevention and treatment of influenza or flu in the US. Under the terms of...Read more

Medtronic partners with Viz.ai

World |  News | 0 Comment | 24 Jul, 2019

Medtronic plc, a global leader in medical technology, and Viz.ai, the emerging leader in applied artificial intelligence (AI) in stroke care, have partnered to accelerate the adoption of Vi...Read more

NIH publishes largest genomic study on type 2 diabetes in sub-Saharan African populations

World |  News | 0 Comment | 23 Jul, 2019

National Institute of Health researchers have reported the largest genomic study of type 2 diabetes (T2D) in sub-Saharan Africans, with data from more than 5,000 individuals from Nigeria, G...Read more

Yellow Wood Partners to acquire Dr. Scholl’s from Bayer

World |  News | 0 Comment | 23 Jul, 2019

Yellow Wood Partners has entered into a definitive agreement to buy the Dr. Scholl’s™ business from Bayer for a purchase price of 585 million U.S. dollars.  Dr. Scholl&rsq...Read more

WHO recommends dolutegravir as preferred HIV treatment option

World |  News | 0 Comment | 23 Jul, 2019

Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all populations, ...Read more

Medicxi closes €400m Fund (Medicxi III)

World |  News | 0 Comment | 22 Jul, 2019

Leading European life sciences investment firm Medicxi has announced the closing of Medicxi III, a new €400 million fund. This brings the total amount raised by Medicxi in the last thr...Read more

Merck and Broad Institute announce CRISPR license framework

World |  News | 0 Comment | 19 Jul, 2019

Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) have announced an agreement to offer non-exclusive li...Read more